Decision Aid for Parents of Infants With UPJO

Launched by UNIVERSITY OF COLORADO, DENVER · Jun 8, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at a decision-making tool for parents of infants who have a condition called ureteropelvic junction obstruction (UPJO). This condition can cause severe swelling in the kidneys, which can lead to kidney damage if not treated properly. The trial aims to help parents understand their options—whether to consider early surgery or to monitor the situation before making a decision. Since different doctors may have varying opinions on the best approach, this tool is designed to help parents feel more informed and engaged in the decision-making process for their child's care.

To be eligible for this trial, parents must be between 18 and 89 years old and have a child aged between 30 days and 2 years who is being evaluated for high-grade hydronephrosis at Children's Hospital Colorado. Participants will be involved in discussions about their child’s treatment options and will use the decision aid to help clarify their choices. This trial is an important step towards improving how families make treatment decisions for their children with UPJO, and it could lead to better outcomes in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria (all of following are needed):
• • parents (age 18-89 years) of children age 30 days - 2 years
• • child is presenting for consultation for SFU grade 3-4 Hydronephrosis at Children's Hospital Colorado
• • parents/child presenting at Urology appointment where a MAG 3 is performed or has recently been performed.
• Exclusion Criteria:
• • does not meet age parameters
• • does not have a child with a UPJO